Clinical Trials Directory

Trials / Conditions / Relapsed Chronic Lymphocytic Leukemia

Relapsed Chronic Lymphocytic Leukemia

11 registered clinical trials studyying Relapsed Chronic Lymphocytic Leukemia — 2 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingA Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
NCT05828589
BeOne MedicinesPhase 1
RecruitingAllo HSCT Using RIC and PTCy for Hematological Diseases
NCT05805605
Masonic Cancer Center, University of MinnesotaPhase 2
Active Not RecruitingStudy of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocyt
NCT05479994
BeiGenePhase 2
RecruitingVenetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
NCT05246345
University Hospital, Clermont-Ferrand—
Active Not RecruitingAcalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
NCT04624633
Jennifer R. Brown, MD, PhDPhase 2
WithdrawnRituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL
NCT03639324
Virginia Commonwealth UniversityPhase 1
TerminatedStudy of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
NCT04305444
Zhejiang DTRM BiopharmaPhase 2
CompletedReduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
CompletedUCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT02722668
Masonic Cancer Center, University of MinnesotaPhase 2
CompletedIntra-Osseous Co-Transplant of UCB and hMSC
NCT02181478
Case Comprehensive Cancer CenterEARLY_Phase 1
CompletedA Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated
NCT01750567
University of Michigan Rogel Cancer CenterPhase 2